BMAL1, which is one of the most important circadian clock genes, regulates overall circadian oscillations in humans, and previous reports have suggested that reduced BMAL1 is closely associated with tumor progression in cancer cells [16,17,18]. This evidence concerns the gene CLOCK and neoplasm.